World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
39580
World Ranking
7948
National Ranking
243

Raoul Poupon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raoul Poupon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 383 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raoul Poupon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raoul Poupon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Raoul Poupon is affiliated with Sorbonne University in France and specializes in the field of Medicine, with a focus on Hepatology, Epidemiology, and Pathology and Forensic Medicine. Their work centers on liver diseases and immunity, liver disease diagnosis and treatment, as well as genetic factors in colorectal cancer.

Their research contributions include a published paper titled "A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA," which appeared in the Journal of Hepatology in 2020. This paper has attracted notable citations in the field.

Throughout their career, Raoul Poupon has frequently collaborated with several co-authors, including:

  • Gideon M. Hirschfield
  • Ulrich Beuers
  • Limas Kupčinskas
  • Peter Ott
  • Annika Bergquist

Their work has been consistently published in the Journal of Hepatology, a venue that features prominently in their academic output.

The main areas of study explored by Raoul Poupon include:

  • Medicine

Their specialization further breaks down into the following subfields:

  • Hepatology
  • Epidemiology
  • Pathology and Forensic Medicine

Raoul Poupon's research covers key topics such as:

  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Genetic factors in colorectal cancer

Best Publications

  • Primary Biliary Cirrhosis

    Keith D. Lindor;M. Eric Gershwin;Raoul Poupon;Marshall Kaplan

  • Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

    Nicolas Carbonell;Arnaud Pauwels;Lawrence Serfaty;Olivier Fourdan

  • Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

    Magali Sasso;Michel Beaugrand;Victor de Ledinghen;Catherine Douvin

  • Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

    Henri Duboc;Sylvie Rajca;Sylvie Rajca;Dominique Rainteau;Dominique Rainteau;David Benarous

  • A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.

    Renée E. Poupon;Beverley Balkau;Eveline Eschwège;Raoul Poupon

  • Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy

    Olivier Chazouillères;Dominique Wendum;Lawrence Serfaty;Sarah Montembault

  • Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

    Christophe Corpechot;Ludovico Abenavoli;Nabila Rabahi;Yves Chrétien

  • Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

    RE Poupon;KD Lindor;K Cauch-Dudek;ER Dickson

  • IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS

    Raoul Poupon;RenéeE. Poupon;Yvon Calmus;Yves Chrétien

  • Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis

    Jean-Claude Homberg;Nisen Abuaf;Olivier Bernard;Shamsul Islam

  • Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

    Patrick Marcellin;Marianne Ziol;Pierre Bedossa;Catherine Douvin

  • Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

    Renee E. Poupon;Raoul Poupon;Beverley Balkau

  • Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

    Christophe Corpechot;Veronique Barbu;Dominique Wendum;Nils Kinnman

  • A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

    Christophe Corpechot;Olivier Chazouillères;Alexandra Rousseau;Antonia Le Gruyer

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

    Christophe Corpechot;Ahmed El Naggar;Armelle Poujol-Robert;Marianne Ziol

  • Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

    Ulrich H W Beuers;M Eric Gershwin;Robert G Gish;Pietro Luigi Invernizzi

  • New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

    Ulrich Beuers;Michael Trauner;Peter Jansen;Raoul Poupon

  • Determinants of outcome of compensated hepatitis C virus-related cirrhosis

    Lawrence Serfaty;Hugues Aumaître;Olivier Chazouillères;Anne-Marie Bonnand

  • Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

    L Fartoux;A Poujol-Robert;J Guéchot;D Wendum

Frequent Co-Authors

Olivier Chazouillères
Olivier Chazouillères Université Paris Cité
Albert Parés
Albert Parés University of Barcelona
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Keith D. Lindor
Keith D. Lindor Arizona State University
Bettina E. Hansen
Bettina E. Hansen University Health Network
Cyriel Y. Ponsioen
Cyriel Y. Ponsioen University of Amsterdam
Kris V. Kowdley
Kris V. Kowdley Washington State University
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Fabrice Carrat
Fabrice Carrat Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens the door to numerous related online degrees and career pathways, many of which can be started or advanced through online study. Healthcare is a broad field, and not everyone needs to attend traditional medical school to make an impact or build a rewarding career.

For those interested in the administrative side, cheapest medical billing and coding online courses offer a practical pathway into medical records and billing, a critical field with growing demand.

Aspiring nurses have more options than ever. You can compare cheapest np school programs and fully-accredited nursing school online opportunities, making it possible to launch or advance your nursing career according to your schedule and budget.

For nurses aiming for leadership or academic roles, pursuing the cheapest online dnp programs can be a strategic next step. Each of these routes offers affordable, flexible pathways tailored to a range of healthcare interests and professional goals.

Best Scientists Citing Raoul Poupon

Trending Scientists

Recently Published Articles